Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2009-10-7
pubmed:abstractText
Neuroinflammation is a hallmark of several neurodegenerative diseases, including Alzheimer's disease (AD). Strong epidemiological and experimental evidence supports the use of nonsteroidal anti-inflammatory drugs to reduce AD risk. However, poor outcome in clinical trials and toxicity in a prevention trial have shifted focus away from these cyclooxygenase (COX) inhibitors to seek additional therapeutic targets in the prostaglandin pathway. Previously, the prostaglandin E2 receptor, EP2, was shown to regulate neuroinflammation and reduce Abeta plaque burden in transgenic mice. Unfortunately, widespread EP2 distribution and a direct effect on COX2 induction make EP2 a less desirable target. In this study, we link dedicator of cytokinesis 2 (DOCK2) to the prostaglandin pathway in the brain. Additionally, we show that DOCK2 regulates microglial innate immunity independent of COX2 induction and that DOCK2+ microglia are associated with human AD pathology. Together, these results suggest DOCK2 as a COX2 expression-independent therapeutic target for neurodegenerative diseases such as AD.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase 2, http://linkedlifedata.com/resource/pubmed/chemical/DOCK2 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/DOCK2 protein, mouse, http://linkedlifedata.com/resource/pubmed/chemical/GTPase-Activating Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Guanine Nucleotide Exchange Factors, http://linkedlifedata.com/resource/pubmed/chemical/PTGER2 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Ptger2 protein, mouse, http://linkedlifedata.com/resource/pubmed/chemical/Ptgs2 protein, mouse, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Prostaglandin E, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Prostaglandin E, EP2...
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1525-2191
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
175
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1622-30
pubmed:dateRevised
2011-9-26
pubmed:meshHeading
pubmed-meshheading:19729484-Alzheimer Disease, pubmed-meshheading:19729484-Animals, pubmed-meshheading:19729484-Brain, pubmed-meshheading:19729484-Cyclooxygenase 2, pubmed-meshheading:19729484-GTPase-Activating Proteins, pubmed-meshheading:19729484-Gene Expression Regulation, pubmed-meshheading:19729484-Guanine Nucleotide Exchange Factors, pubmed-meshheading:19729484-Humans, pubmed-meshheading:19729484-Immunity, Innate, pubmed-meshheading:19729484-Mice, pubmed-meshheading:19729484-Mice, Inbred C57BL, pubmed-meshheading:19729484-Microglia, pubmed-meshheading:19729484-Organ Specificity, pubmed-meshheading:19729484-Protein Transport, pubmed-meshheading:19729484-RNA, Messenger, pubmed-meshheading:19729484-Receptors, Prostaglandin E, pubmed-meshheading:19729484-Receptors, Prostaglandin E, EP2 Subtype
pubmed:year
2009
pubmed:articleTitle
DOCK2 is a microglial specific regulator of central nervous system innate immunity found in normal and Alzheimer's disease brain.
pubmed:affiliation
Division of Neuropathology, Department of Pathology, the Neurobiology and Behavior Program, University of Washington, Box 359645, Harborview Medical Center, Seattle, WA 98104, USA. pjjc@u.washington.edu
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural